TrialCNS drugs2018

MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study.

Ayman Tourbah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.